塞沃兰通过抑制内部神经元上含有GluN2D的NMDA受体而起抗抑郁作用
Fei Guo1,2, Bing Zhang1, Fuyi Shen1
1Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Department of Anesthesiology, Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China.
British journal of pharmacology
|May 23, 2024
概括
麻醉剂Sevoflurane通过向N-甲基-d-酸盐受体的GluN2D亚单元,表现出抗抑郁作用. 这种机制降低了内部神经元的活动,提供了潜在的新的抑郁症治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 塞沃弗兰是一种广泛使用的吸入麻醉剂,具有良好的安全性.
- 它的潜在抗抑郁药物特性和潜在机制在很大程度上仍未被探索.
- 这项研究调查了sevoflurane的抗抑郁作用和相关的神经生物学途径.
研究的目的:
- 为了阐明sevoflurane抗抑郁作用的作用机制.
- 为了确定sevoflurane是否针对中部前额皮层 (mPFC) 中的N-甲基-d-酸盐受体 (NMDARs).
- 评估GluN2D亚单元在赛沃兰抗抑郁作用中的作用.
主要方法:
- 在小鼠中进行行为测试,以评估抗抑郁药的效果.
- 在体外和体外全细胞补丁记录mPFC中的NMDARs.
- 电生理学在自由移动的小鼠中评估神经元活动.
- 使用GluN2D淘汰 (grin2d-/-) 鼠标来确认GluN2D.的作用.
主要成果:
- 重复的亚麻醉性塞沃弗卢兰剂量诱导持续抗抑郁作用长达两周.
- 塞沃兰选择性地抑制了含有GluN2C和GluN2D的NMDAR,降低了内部神经元的活动.
- 赛沃氨酸增加了金字塔神经元的发射,并减少了抑制电流,表明无抑制. 这些效应依赖于GluN2D.
结论:
- 塞沃兰的抗抑郁作用通过直接向GluN2D亚单元来调节.
- 这导致内部神经元活动降低和mPFC金字塔神经元的消抑制.
- 准GluN2D亚单元代表了抑郁症的有前途的治疗策略.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
225
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
225
Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
Inhalational Anesthetics: Overview
264
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
264
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Sedatives and Hypnotics: Overview
347
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
347
Parenteral Anesthetics: Overview
118
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
118


